Literature DB >> 26998093

Reduced expression of caspase-8 and cleaved caspase-3 in pancreatic ductal adenocarcinoma cells.

Katarzyna Jakubowska1, Katarzyna Guzińska-Ustymowicz1, Waldemar Famulski2, Dariusz Cepowicz3, Dorota Jagodzińska1, Anna Pryczynicz1.   

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is a rare neoplasm that affects the gastrointestinal system, and is characterized by a high mortality rate. It has been demonstrated that apoptosis has a significant role in the regulation of cancer cells. Therefore, the aim of the present study was to immunohistochemically assess the expression of proteins belonging to the caspase family, namely caspase-8, pro-caspase-3 and cleaved (active) caspase-3 in pancreatic cancer. The study group consisted of 29 patients exhibiting PDAC. Protein expression was evaluated by immunohistochemical methods. The expression of caspase-8 in normal cells was negative in 17.2% of cases and positive in 82.8% of cases. All cases demonstrated pro-caspase-3 expression in normal pancreatic cells, compared with 93.1% of cancer cells. Staining for activated caspase-3 was positive in 27 normal tissue cases, compared with positivity in only 10 cancer cases. Caspase-8 expression positively correlated with cleaved caspase-3 expression in the cytoplasm of cancer cells (P<0.002). Caspase-3 expression was identified to correlate with inflammatory peritumoral infiltration (P<0.015). No correlation was observed between caspase expression and any other clinicopathological parameters. The results of the present study demonstrated aberrant initiation of cancer cell apoptosis in PDAC via a decrease in caspase-8 expression, which may lead to disorders in the activation of effector caspase-3.

Entities:  

Keywords:  apoptosis; caspase expression; immunohistochemistry; pancreatic ductal cancer

Year:  2016        PMID: 26998093      PMCID: PMC4774510          DOI: 10.3892/ol.2016.4125

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  18 in total

Review 1.  Early events in acute pancreatitis.

Authors:  M L Steer
Journal:  Baillieres Best Pract Res Clin Gastroenterol       Date:  1999-07

Review 2.  Cell death pathways in pancreatitis and pancreatic cancer.

Authors:  Anna S Gukovskaya; Stephen J Pandol
Journal:  Pancreatology       Date:  2004-11-16       Impact factor: 3.996

3.  Cleaved caspase-3 immunocytochemical staining for pancreatic islets and pancreatic endocrine tumors: A potential marker for biological malignancy.

Authors:  Tatsuo Tomita
Journal:  Islets       Date:  2010 Mar-Apr       Impact factor: 2.694

4.  Immunohistochemical analysis of cell death pathways in gastrointestinal adenocarcinoma.

Authors:  Michiko Shintani; Akiko Sangawa; Naoki Yamao; Toshihiko Miyake; Shingo Kamoshida
Journal:  Biomed Res       Date:  2011-12       Impact factor: 1.203

5.  Fas and Fas-ligand expression in human pancreatic cancer.

Authors:  M Kornmann; T Ishiwata; J Kleeff; H G Beger; M Korc
Journal:  Ann Surg       Date:  2000-03       Impact factor: 12.969

Review 6.  Histopathologic assessment of pancreatic cancer: does one size fit all?

Authors:  Michelle D Reid; Pelin Bagci; N Volkan Adsay
Journal:  J Surg Oncol       Date:  2012-06-18       Impact factor: 3.454

7.  Extracellular matrix proteins protect pancreatic cancer cells from death via mitochondrial and nonmitochondrial pathways.

Authors:  Eva C Vaquero; Mouad Edderkaoui; Kyung J Nam; Ilya Gukovsky; Stephen J Pandol; Anna S Gukovskaya
Journal:  Gastroenterology       Date:  2003-10       Impact factor: 22.682

8.  Expression and prognostic significance of APAF-1, caspase-8 and caspase-9 in stage II/III colon carcinoma: caspase-8 and caspase-9 is associated with poor prognosis.

Authors:  Jörn Sträter; Ines Herter; Gaby Merkel; Ulf Hinz; Jürgen Weitz; Peter Möller
Journal:  Int J Cancer       Date:  2010-08-15       Impact factor: 7.396

9.  C-JUN and CPP32 (CASPASE 3) in human pancreatic cancer: relation to cell proliferation and death.

Authors:  Tamara Meggiato; Fiorella Calabrese; Cristina Maria De Cesare; Elisabetta Baliello; Marialuisa Valente; Giuseppe Del Favero
Journal:  Pancreas       Date:  2003-01       Impact factor: 3.327

10.  Endogenous decoy receptor 3 blocks the growth inhibition signals mediated by Fas ligand in human pancreatic adenocarcinoma.

Authors:  Shoichiro Tsuji; Ryo Hosotani; Shin Yonehara; Toshihiko Masui; Sidhartha S Tulachan; Sanae Nakajima; Hiroyuki Kobayashi; Masayuki Koizumi; Eiji Toyoda; Daisuke Ito; Kazuhiro Kami; Tomohiko Mori; Koji Fujimoto; Ryuichiro Doi; Masayuki Imamura
Journal:  Int J Cancer       Date:  2003-08-10       Impact factor: 7.396

View more
  8 in total

1.  Procaspase-3 Overexpression in Cancer: A Paradoxical Observation with Therapeutic Potential.

Authors:  Matthew W Boudreau; Jessie Peh; Paul J Hergenrother
Journal:  ACS Chem Biol       Date:  2019-07-16       Impact factor: 5.100

2.  Expression levels of cleaved caspase-3 and caspase-3 in tumorigenesis and prognosis of oral tongue squamous cell carcinoma.

Authors:  Pei-Feng Liu; Yu-Chang Hu; Bor-Hwang Kang; Yu-Kai Tseng; Pi-Chuang Wu; Chi-Chuang Liang; Yu-Yi Hou; Ting-Ying Fu; Huei-Han Liou; I-Chien Hsieh; Luo-Ping Ger; Chih-Wen Shu
Journal:  PLoS One       Date:  2017-07-10       Impact factor: 3.240

3.  Towards Prognostic Profiling of Non-Small Cell Lung Cancer: New Perspectives on the Relevance of Polo-Like Kinase 1 Expression, the TP53 Mutation Status and Hypoxia.

Authors:  Jolien Van den Bossche; Christophe Deben; Ken Op de Beeck; Vanessa Deschoolmeester; Christophe Hermans; Ines De Pauw; Julie Jacobs; Paul Van Schil; Jan Baptist Vermorken; Patrick Pauwels; Marc Peeters; Filip Lardon; An Wouters
Journal:  J Cancer       Date:  2017-05-12       Impact factor: 4.207

4.  Caspase-3 expression in tumorigenesis and prognosis of buccal mucosa squamous cell carcinoma.

Authors:  Jer-Shyung Huang; Cheng-Mei Yang; Jyh-Seng Wang; Huei-Han Liou; I-Chien Hsieh; Guan-Cheng Li; Sin-Jhih Huang; Chih-Wen Shu; Ting-Ying Fu; Yun-Chung Lin; Luo-Ping Ger; Pei-Feng Liu
Journal:  Oncotarget       Date:  2017-08-24

5.  Tiliroside as a CAXII inhibitor suppresses liver cancer development and modulates E2Fs/Caspase-3 axis.

Authors:  Rui Han; Hongxing Yang; Lingeng Lu; Lizhu Lin
Journal:  Sci Rep       Date:  2021-04-21       Impact factor: 4.379

Review 6.  Debris-stimulated tumor growth: a Pandora's box?

Authors:  Victoria M Haak; Sui Huang; Dipak Panigrahy
Journal:  Cancer Metastasis Rev       Date:  2021-10-19       Impact factor: 9.264

7.  Establishment and evaluation of ectopic and orthotopic prostate cancer models using cell sheet technology.

Authors:  Dongliang Zhang; Ying Wang; Lei Liu; Zeng Li; Shengke Yang; Weixin Zhao; Xiang Wang; Hong Liao; Shukui Zhou
Journal:  J Transl Med       Date:  2022-08-29       Impact factor: 8.440

8.  LncRNA MEG3 influences the proliferation and apoptosis of psoriasis epidermal cells by targeting miR-21/caspase-8.

Authors:  Hai-Yan Jia; Kai Zhang; Wen-Jing Lu; Gui-Wen Xu; Jian-Fen Zhang; Zhan-Li Tang
Journal:  BMC Mol Cell Biol       Date:  2019-10-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.